Zosano Pharma Corp (ZSAN) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 86 transactions totaling $7.3M, demonstrating a bearish sentiment with -$3.5M in net insider flow. The most recent transaction on Jun 6, 2022 involved a sale of 442 shares valued at $314.
No significant insider buying has been recorded for ZSAN in the recent period.
No significant insider selling has been recorded for ZSAN in the recent period.
Based on recent SEC filings, insider sentiment for ZSAN is bearish with an Insider Alignment Score of 26/100 and a net flow of -$3.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Zosano Pharma Corp (ZSAN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading ZSAN stock, having executed 86 transactions in the past 90 days. The most active insider is M. James Barrett (Executive), who has made 11 transactions totaling $5.8M.
Get notified when executives and directors at ZSAN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 6, 2022 | Lo Steven | Executive | Sale | 442 | $0.71 | $314 | |
| Jun 6, 2022 | Matthews Christine | Executive | Sale | 82 | $0.71 | $58 | |
| Mar 31, 2022 | Lo Steven | Executive | Sale | 23,633 | $0.21 | $5.0K | |
| Mar 31, 2022 | J. Kellerman Donald | Executive | Sale | 4,006 | $0.21 | $841 | |
| Mar 31, 2022 | Matthews Christine | Executive | Sale | 8,116 | $0.21 | $1.7K | |
| Nov 23, 2021 | Greathouse Kenneth | Executive | Sale | 10,000 | $0.60 | $6.0K | |
| Oct 15, 2021 | Lo Steven | Executive | Award | 118,750 | $N/A | $0 | |
| Oct 15, 2021 | Matthews Christine | Executive | Award | 56,250 | $N/A | $0 | |
| Oct 15, 2021 | J. Kellerman Donald | Executive | Award | 10,000 | $N/A | $0 | |
| Jun 10, 2021 | P. Hagan Joseph | Executive | Award | 15,000 | $N/A | $0 | |
| Jun 10, 2021 | G. Xanthopoulos Kleanthis | Executive | Award | 15,000 | $N/A | $0 | |
| Jun 10, 2021 | Greathouse Kenneth | Executive | Award | 15,000 | $N/A | $0 | |
| Jun 10, 2021 | Elms Steve | Executive | Award | 15,000 | $N/A | $0 | |
| Jun 10, 2021 | Grais Linda | Executive | Award | 15,000 | $N/A | $0 | |
| Jun 4, 2021 | Matthews Christine | Executive | Sale | 1,709 | $0.81 | $1.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 4 | $10.0M | 49.8% |
Sale(S) | 31 | $5.4M | 27.1% |
Award(A) | 28 | $2.5M | 12.6% |
Purchase(P) | 20 | $1.9M | 9.7% |
Exercise(M) | 2 | $184.7K | 0.9% |
Disposition(D) | 1 | $0 | 0.0% |
Insider selling pressure at Zosano Pharma Corp has increased, with 23 insiders executing 86 transactions across all time. Total sales of $5.4M significantly outpace purchases of $1.9M, resulting in a net outflow of $3.5M. This selling activity appears largely discretionary, which may warrant closer attention from investors.